First Line Osimertinib for EGFR Mutation-positive Non-Small Cell Lung Cancer in Real World Chinese Setting
Clinical trial NCT04391283 · UNKNOWN
Trial details
- NCT number
- NCT04391283
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-27
- Primary completion
- 2022-04-26
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.